Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 11, 2023, titled "Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 11, 2023, titled "Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program".